Why the study?
Does in-house point-of-care measurement of thrombin-antithrombin complex accurately detect disseminated intravascular coagulation in dogs?
Does in-house point-of-care measurement of thrombin-antithrombin complex accurately detect disseminated intravascular coagulation in dogs?
Answers are grounded in this paper and cite their sources.
In-house TAT measurement using a point-of-care device is a clinically relevant and useful tool for the early detection of canine disseminated intravascular coagulation.
Reference interval for thrombin-antithrombin complex (TAT) level was determined using an in-house TAT measurement device, and its validity for diagnosis of disseminated intravascular coagulation (DIC) was evaluated in dogs. One hundred and two clinically healthy dogs and 247 diseased dogs with conditions that potentially caused DIC were recruited in the study. Six diagnostic testing for DIC were evaluated in diseased dogs and the diseased dogs were categorized into five groups depending on abnormal findings. TAT was measured in all study animals and between-group differences were evaluated. TAT level was positively associated with severity of DIC. There were no significant differences in TAT levels among clinically healthy dogs, diseased dogs without any abnormal finding and diseased dogs with one abnormal finding in the DIC diagnostic testing. TAT levels in groups with two or more abnormal findings were significantly higher than clinically healthy dogs. Reference interval of TAT level for clinically healthy dogs was ≤ 0.25 ng/ml. Validity of using TAT for early detection of DIC was evaluated. In-house TAT measurement was suggested to be a clinically relevant and useful tool for early detection of canine DIC.
No takes yet. Share an insight, caveat, or question.
Rimpo et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: